Combivent Respimat (Boehringer Ingelheim Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Combivent Respimat drug offered from Boehringer Ingelheim Pharmaceuticals Inc.. This Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Boehringer Ingelheim Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | ipratropium bromide and albuterol |
SUBSTANCE NAME: | IPRATROPIUM BROMIDE; ALBUTEROL SULFATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Anticholinergic [EPC],Cholinergic Antagonists [MoA],Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC] |
ROUTE: | RESPIRATORY (INHALATION) |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
Combivent Respimat HUMAN PRESCRIPTION DRUG Details:
Item Description | Combivent Respimat from Boehringer Ingelheim Pharmaceuticals Inc. |
LABELER NAME: | Boehringer Ingelheim Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 20; 120(ug/1; ug/1) |
START MARKETING DATE: | 2012-07-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0597-0024_7ee08565-596d-951a-c695-831c58545f09 |
PRODUCT NDC: | 0597-0024 |
APPLICATION NUMBER: | NDA021747 |
Other IPRATROPIUM BROMIDE; ALBUTEROL SULFATE Pharmaceutical Manufacturers / Labelers: